Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer
NCT ID: NCT00383279
Last Updated: 2018-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2006-02-28
2007-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This research study is looking at ways to improve employment in patients who have survived cervical cancer, uterine cancer, or ovarian cancer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life in Survivors of Gynecologic Cancer
NCT00003795
Sexual Functioning in Cervical Cancer Survivors
NCT00522223
Psychosocial Support for African-American, Latina-American, or European-American Cervical Cancer Survivors
NCT00915889
Development & Validation of Utilities for Health States Relevant to Cervical Cancer Patients
NCT00788216
Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications
NCT01039493
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Conduct formative work, including 4 to 5 focus groups, leading to development of a structured interview instrument assessing factors related to employment outcomes among women with gynecologic cancers.
* Pilot a recruitment strategy and administer the interview among a sample of 60 to 70 gynecologic cancer survivors; and, with each woman's permission, a family member, a key health care provider, and her supervisor will be interviewed.
OUTLINE: This is a multicenter, pilot study.
Patients complete a survey, meet with a focus group, and undergo a short interview. Patient-designated participants are also interviewed; these individuals may include a health care provider, a significant other, and/or a work supervisor.
PROJECTED ACCRUAL: A total of 70 patients will be accrued for this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
counseling intervention
study of socioeconomic and demographic variables
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of 1 of the following invasive cancers:
* Cervical cancer
* Uterine cancer
* Ovarian cancer
* Diagnosed ≥ 6 months ago
* Any stage disease
* Employed at the time of diagnosis, defined as working for pay ≥ 20 hours/week
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* Not specified
18 Years
120 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brigitte E. Miller, MD
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCCWFU-99106
Identifier Type: -
Identifier Source: secondary_id
CCCWFU-BG06-014
Identifier Type: -
Identifier Source: secondary_id
CCCWFU-99106
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.